Such is the case with newly approved Bristol-Myers Squibb drug Cobenfy. The underlying drug was first studied in Alzheimer’s ...
Researchers have found that the drug dronabinol — a synthetic version of the psychoactive THC compound in cannabis — helped ...
Sage Therapeutics said on Tuesday it would stop developing its experimental drug, dalzanemdor, for Alzheimer's disease after ...
Dronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a stu ...
The five big factors increasing the risk for cognitive decline, dementia or both: diabetes, midlife hypertension or high ...
Sage Therapeutics Inc.’s stock tumbled 12.8% early Tuesday, after the company said a mid-stage trial of a treatment for mild ...
Scientists have developed a novel peptide that could potentially revolutionize the treatment of Alzheimer's disease and other neurodegenerative disorders known as tauopathies.
An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...
Walk for hope. Walk for a loved one. Walk for a cure. Late October, nearly a hundred participants across 19 teams in LaGrange ...
Microglia are the brain's resident immune cells. Their job is to patrol the brain's blood vessels looking for invading ...
What I really hope for is to be functional and continue to do as many things as I can possibly do,” says Virginia Arey of ...